IPO - Nukkleus Inc.

Form Type: S-1

Filing Date: 2025-02-12

Corporate Action: Ipo

Type: New

Accession Number: 000121390025013050

Filing Summary: Nukkleus Inc. is registering 4,429,165 shares of common stock, including shares issuable upon the exercise of pre-funded warrants and common warrants. The securities will be offered by selling stockholders, who will sell shares at fixed, market, or negotiated prices. The company is not receiving proceeds from the sale of shares; however, it will receive proceeds from any cash exercised warrants. The document also outlines the structure and purpose of the company, following a business combination completed on December 22, 2023, and aims to provide blockchain-enabled financial technology solutions. The business focus has shifted to defense technology solutions with recent acquisitions and partnerships. Risk factors associated with investing are highlighted, and previous transactions related to debt restructuring and changes in stock structure, including a recent reverse stock split, are detailed.

Document Link: View Document